Targeted D4 dopamine receptors: implications for drug discovery and therapeutic development.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Drug Targets

• Publication date

  2013-03-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389450111314040012PMID 23469923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An historical perspective on “The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus”

  2014cited by this paper
• Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs

  2012cited by this paper
• Molecular Combination of the Dopamine and Serotonin Scaffolds Yield in Novel Antipsychotic Drug Candidates – Characterization by in vivo Experiments

  2012cited by this paper
• Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.

  2012cited by this paper
• Dopamine receptor interacting proteins: targeting neuronal calcium sensor-1/D2 dopamine receptor interaction for antipsychotic drug development.

  2012cited by this paper
• Best friends and alcohol use in adolescence: the role of the dopamine D4 receptor gene

  2012cited by this paper
• Effect of model choice in genetic association studies: DRD4 exon III VNTR and cigarette use in young adults

  2011cited by this paper
• Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice.

  2011cited by this paper
• Association between neonatal temperament, SLC6A4, DRD4 and a functional polymorphism located in TFAP2B

  2011cited by this paper
• Dopamine selectively modulates lipopolysaccharide-induced TNF-alpha, IFN-gamma and IL-10 within mice tissues.

  2011cited by this paper
• Genetics in Psychiatry - up-to-date review 2011.

  2011cited by this paper
• Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients.

  2011cited by this paper
• Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia

  2011cited by this paper
• Association between polymorphisms of DRD2 and DRD4 and opioid dependence: Evidence from the current studies

  2011cited by this paper
• The neurobiological link between compassion and love

  2011cited by this paper
• L-DRD4 genotype not associated with sensation seeking, gambling performance and startle reactivity in adolescents: the TRAILS study.

  2011cited by this paper
• A role for the DRD4 exon III VNTR in modifying the association between nicotine dependence and neuroticism.

  2011cited by this paper
• Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders

  2011cited by this paper
• The molecular genetics of executive function: role of monoamine system genes.

  2011cited by this paper
• Pharmacogenetic approach for a better drug treatment in children.

  2010cited by this paper
• Halogen atoms in the modern medicinal chemistry: hints for the drug design.

  2010cited by this paper
• DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics

  2010cited by this paper
• Individualized treatment of eating disorders.

  2010cited by this paper
• Proinflammation and preconditioning protection are part of a common nitric oxide mediated process.

  2010cited by this paper
• Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction.

  2010cited by this paper
• The effect of chemical sympathectomy and stress on bone remodeling in adult rats.

  2010cited by this paper
• Endogenous cannabinoid and opioid systems and their role in nicotine addiction.

  2010cited by this paper
• Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.

  2010cited by this paper
• Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactivity disorder: a two-night polysomnographic study with a multiple sleep latency test.

  2010cited by this paper
• Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.

  2010cited by this paper
• The neurobiology of stress management.

  2010cited by this paper
• The protective action of topiramate on dopaminergic neurons.

  2010cited by this paper
• Genetic Polymorphisms in Dopamine- and Serotonin-Related Genes and Treatment Responses to Risperidone and Perospirone

  2009cited by this paper
• Cognitive and emotional processing in high novelty seeking associated with the L-DRD4 genotype.

  2009cited by this paper
• Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors.

  2009cited by this paper
• ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys.

  2009cited by this paper
• DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

  2009cited by this paper
• Anthropometric changes in non-medicated ADHD boys.

  2009cited by this paper
• Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya

  2008cited by this paper
• A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa.

  2008cited by this paper
• Genetic loading on human loving styles.

  2007cited by this paper
• [Pharmacogenetics and treatment response in schizophrenia].

  2007cited by this paper
• Serotonin-dopamine interaction as a focus of novel antidepressant drugs.

  2006cited by this paper
• Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines

  2006cited by this paper
• Antipsychotic medications in the treatment of bipolar disorder.

  2006cited by this paper
• DOPAMINE D4 RECEPTOR GENE EXON III POLYMORPHISM AND INTERINDIVIDUAL VARIATION IN RESPONSE TO CLOZAPINE

  2005cited by this paper
• Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.

  2004cited by this paper
• Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD.

  2004cited by this paper
• DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study.

  2003cited by this paper
• Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis.

  2003cited by this paper
• Evidence of positive selection acting at the human dopamine receptor D4 gene locus

  2001cited by this paper
• Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.

  2001cited by this paper
• Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia

  2000cited by this paper
• Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

  2000cited by this paper
• Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD)

  2000cited by this paper
• Dopamine D4 receptors and development of newer antipsychotic drugs

  2000cited by this paper
• Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs

  1999cited by this paper
• Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia.

  1998cited by this paper
• Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.

  1997cited by this paper
• Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.

  1996cited by this paper
• Efficacy and Side-Effects of Clozapine: Testing for Association with Allelic Variation in the Dopamine D4 Receptor Gene

  1996cited by this paper
• Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients.

  1995cited by this paper
• Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors.

  1994cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine.

  1994cited by this paper
• Multiple dopamine D4 receptor variants in the human population

  1992cited by this paper

• Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease

  2024cites this paper
• Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective.

  2022cites this paper
• Palmitoylation of the carboxyl-terminal tail of dopamine D4 receptor is required for surface expression, endocytosis, and signaling.

  2016cites this paper